Filing Flows › Connect Biopharma Holdings (CNTB) › How it makes money
How Connect Biopharma Holdings (CNTB) makes money
Connect Biopharma Holdings (CNTB) made $2.8M of revenue in the second quarter 2026 (Q2 2026), up 58-fold from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $2.8M | 100.0% |
| Income tax | $60K | 2.2% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $2.8M | 58× |
| Q1 2026 | $169K | — |
| Q3 2025 | $16K | -99% |
| Q2 2025 | $48K | -100% |
| Q4 2024 | $698K | — |
From Connect Biopharma Holdings' 10-Q filed Aug 12, 2026 (on EDGAR).
Questions
How does Connect Biopharma Holdings make money?
Connect Biopharma Holdings (CNTB) made $2.8M of revenue in the second quarter 2026 (Q2 2026), up 58-fold from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.